DXS International (AQSE:DXSP) Cash Flow from Operations: £0.40 Mil (TTM As of Apr. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is DXS International Cash Flow from Operations?

DXS International AQSE:DXSP Cash Flow from Operations is £0.40 Mil as of Apr. 2025. The stock has 5 warning signs investors should review.

Cash flow from operations refers to the cash brought in through a company's normal business operations. It is the cash flow before any investment or financing activities. It is the cash version of net income.

For the six months ended in Apr. 2025, DXS International's Net Income From Continuing Operations was £-0.13 Mil. Its Depreciation, Depletion and Amortization was £0.00 Mil. Its Change In Working Capital was £0.37 Mil. Its cash flow from deferred tax was £0.00 Mil. Its Cash from Discontinued Operating Activities was £0.00 Mil. Its Asset Impairment Charge was £0.00 Mil. Its Stock Based Compensation was £0.01 Mil. And its Cash Flow from Others was £0.15 Mil. In all, DXS International's Cash Flow from Operations for the six months ended in Apr. 2025 was £0.40 Mil.


DXS International  (AQSE:DXSP) Cash Flow from Operations Explanation

For companies reported in indirect method, cash flow from operations contains six items:

1. Net Income From Continuing Operations:
Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

DXS International's net income from continuing operations for the six months ended in Apr. 2025 was £-0.13 Mil.

2. Depreciation, Depletion and Amortization:
Depreciation is a present expense that accounts for the past cost of an asset that is now providing benefits.
Depletion and amortization are synonyms for depreciation.
Generally:
The term depreciation is used when discussing man made tangible assets
The term depletion is used when discussing natural tangible assets
The term amortization is used when discussing intangible assets

DXS International's depreciation, depletion and amortization for the six months ended in Apr. 2025 was £0.00 Mil.

3. Change In Working Capital:
Working Capital is a measure of a company's short term liquidity or its ability to cover short term liabilities. It is defined as the difference between a company's current assets and current liabilities. Changes in Working Capital is reported in the cash flow statement since it is one of the major ways in which net income can differ from operating cash flow.

DXS International's change in working capital for the six months ended in Apr. 2025 was £0.37 Mil. It means DXS International's working capital increased by £0.37 Mil from Apr. 2024 to Apr. 2025 .

4. Deferred Tax:
It is the cash flow generated from deferred tax.

DXS International's cash flow from deferred tax for the six months ended in Apr. 2025 was £0.00 Mil.

5. Cash from Discontinued Operating Activities:
Net cash from all of the entity's discontinued operating activities.

DXS International's cash from discontinued operating Activities for the six months ended in Apr. 2025 was £0.00 Mil.

6. Asset Impairment Charge:
It is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

DXS International's asset impairment charge for the six months ended in Apr. 2025 was £0.00 Mil.

7. Stock Based Compensation:
It is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

DXS International's stock based compensation for the six months ended in Apr. 2025 was £0.01 Mil.

8. Cash Flow from Others:
These are cash differences caused by the change of inventory, accounts payable, accounts receivable etc. For instance, if a company pays its suppliers slower, its cash position will build up faster. If a company receives payments from its customers slower, its account receivables will rise, and its cash position will grow more slowly (or even shrink).

DXS International's cash flow from others for the six months ended in Apr. 2025 was £0.15 Mil.


DXS International Cash Flow from Operations Related Terms


DXS International Cash Flow from Operations Historical Data

* Premium members only.

The historical data trend for DXS International's Cash Flow from Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DXS International Cash Flow from Operations Chart

DXS International Annual Data
Trend Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25
Cash Flow from Operations
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.24 1.12 0.82 0.58 0.40

DXS International Semi-Annual Data
Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25
Cash Flow from Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 1.24 1.12 0.82 0.58 0.40

DXS International Cash Flow from Operations Calculation

Cash flow from operations refers to the cash brought in through a company's normal business operations. It is the cash flow before any investment or financing activities. It is the cash version of net income.

DXS International's Cash Flow from Operations for the fiscal year that ended in Apr. 2025 is calculated as:

DXS International's Cash Flow from Operations for the quarter that ended in Apr. 2025 is:


For stock reported annually, GuruFocus uses latest annual data as the TTM data. Cash Flow from Operations for the trailing twelve months (TTM) ended in Apr. 2025 was £0.40 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow from Operations of £0.40 Mil mean?
DXS International (AQSE:DXSP) has a Cash Flow from Operations of £0.40 Mil as of Apr. 2025. Cash Flow from Operations is the amount of cash earned or paid from standard business operations. View historical data for DXS International and its competitors.
Is DXS International's Cash Flow from Operations too high?
DXS International's current Cash Flow from Operations is £0.40 Mil.
How does DXS International's Cash Flow from Operations compare to VEEV and BTSG?
DXS International's Cash Flow from Operations of £0.40 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow from Operations for a Healthcare Providers & Services company?
A good Cash Flow from Operations depends on the Healthcare Providers & Services industry context. However, Cash Flow from Operations should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow from Operations mean?
A high Cash Flow from Operations can signal that a stock is expensive relative to its fundamentals. Cash Flow from Operations is the amount of cash earned or paid from standard business operations. View historical data for DXS International and its competitors. DXS International's current Cash Flow from Operations is £0.40 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DXS International stock overvalued right now?
Based on GuruFocus' analysis, DXS International (AQSE:DXSP) is currently considered Fairly Valued. The stock's GF Value™ is £0.02, compared to a current price of £0.02 — trading 5% above its estimated fair value. The current Cash Flow from Operations is £0.40 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow from Operations calculated?
Cash Flow from Operations is calculated from a company's financial statements. For DXS International (AQSE:DXSP), the current Cash Flow from Operations is £0.40 Mil as of Apr. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

DXS International Business Description

Address 119 Saint Mary’s Road, Market Harborough, London, Leicestershire, GBR, LE16 7DT
DXS International PLC is engaged in the development and distribution of clinical decision support systems for General Practitioners, nurses, and retail pharmacies in the United Kingdom and South Africa. Its commercial activities include licensing DXS products to various ICBs, offering e-detailing opportunities to the pharmaceutical industry and the UK primary care sector, and licensing its technology to healthcare publishers. The company's products include BestPathway and Point-of-Care ExpertCare.